Chimeric Viruses Enable Study of Antibody Responses to Human Rotaviruses in Mice
Viruses · 2024
DOI: 10.3390/v16071145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Sarah Woodyear und 8 weiteren Autor:innen. Beteiligte Einrichtung: Baker Institute for Animal Health, Cornell University, Ithaca, NY 14850, USA. Hauptthemen laut MEDLINE: Rotavirus, Rotavirus Infections, Antibodies, Viral, Capsid Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Wellcome Trust, Cornell University.
Abstract (Originalsprache)
The leading cause of gastroenteritis in children under the age of five is rotavirus infection, accounting for 37% of diarrhoeal deaths in infants and young children globally. Oral rotavirus vaccines have been widely incorporated into national immunisation programs, but whilst these vaccines have excellent efficacy in high-income countries, they protect less than 50% of vaccinated individuals in low- and middle-income countries. In order to facilitate the development of improved vaccine strategies, a greater understanding of the immune response to existing vaccines is urgently needed. However, the use of mouse models to study immune responses to human rotavirus strains is currently limited as rotaviruses are highly species-specific and replication of human rotaviruses is minimal in mice. To enable characterisation of immune responses to human rotavirus in mice, we have generated chimeric viruses that combat the issue of rotavirus host range restriction. Using reverse genetics, the rotavirus outer capsid proteins (VP4 and VP7) from either human or murine rotavirus strains were encoded in a murine rotavirus backbone. Neonatal mice were infected with chimeric viruses and monitored daily for development of diarrhoea. Stool samples were collected to quantify viral shedding, and antibody responses were comprehensively evaluated. We demonstrated that chimeric rotaviruses were able to efficiently replicate in mice. Moreover, the chimeric rotavirus containing human rotavirus outer capsid proteins elicited a robust antibody response to human rotavirus antigens, whilst the control chimeric murine rotavirus did not. This chimeric human rotavirus therefore provides a new strategy for studying human-rotavirus-specific immunity to the outer capsid, and could be used to investigate factors causing variability in rotavirus vaccine efficacy. This small animal platform therefore has the potential to test the efficacy of new vaccines and antibody-based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Baker Institute for Animal Health, Cornell University, Ithaca, NY 14850, USA.
- Department of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO 63101, USA.
- Department of Pediatrics, Weill Cornell Medicine, New York, NY 10001, USA.
ORCID-Profile: Sarah Woodyear
Förderung
- NHLBI NIH HHS
- Wellcome Trust
- Cornell University
- Wellcome Trust Clinical Research Career Development Fellowship
Zitieren
APA
Woodyear, S., Chandler, T. L., Kawagishi, T., Lonergan, T. M., Patel, V. A., Williams, C. A., Permar, S. R., Ding, S., & Caddy, S. L. (2024). Chimeric Viruses Enable Study of Antibody Responses to Human Rotaviruses in Mice. Viruses. https://doi.org/10.3390/v16071145
Vancouver
Woodyear S, Chandler TL, Kawagishi T, Lonergan TM, Patel VA, Williams CA, et al. Chimeric Viruses Enable Study of Antibody Responses to Human Rotaviruses in Mice. Viruses. 2024. doi:10.3390/v16071145
BibTeX
@article{Woodyear2024,
author = {Woodyear, Sarah and Chandler, Tawny L and Kawagishi, Takahiro and Lonergan, Tom M and Patel, Vanshika A and Williams, Caitlin A and Permar, Sallie R and Ding, Siyuan and Caddy, Sarah L},
title = {Chimeric Viruses Enable Study of Antibody Responses to Human Rotaviruses in Mice},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16071145}
}
EUVIMED